Method For Treating Hypophosphatemic Bone Diseases Using Fgf-23 Antibody

Abstract

A method for treating a hypophosphatemic bone disease, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition, which contains an antibody that binds to an FGF-23 polypeptide and a pharmaceutically acceptable carrier.


Claims
IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jul 19, 2011
  • Application: Dec 1, 2008
    US US 32555108 A
  • Priority: Dec 1, 2008
    US US 32555108 A
  • Priority: Jul 21, 2003
    US US 34433903 A
  • Priority: Aug 10, 2001
    JP 0106944 W
  • Priority: Apr 19, 2001
    JP 2001121527 A
  • Priority: Dec 22, 2000
    JP 2000391077 A
  • Priority: Sep 21, 2000
    JP 2000287684 A
  • Priority: Aug 11, 2000
    JP 2000245144 A

Download Citation


Sign in to the Lens

Feedback